Claims
- 1. (S)-N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl] acetamide, crystal “Form II ” with a powder X-ray diffraction spectrum of:d-Spacing (Á)Two-Theta Angle (°)Relative Intensity (%)12.447.1029.269.5496.3713.8866.2214.23245.4816.1835.2816.791005.0117.6924.5719.4144.5019.6924.4519.9364.1121.61153.9722.39233.8922.8443.7823.5273.6824.1613.5225.28133.3426.6613.3027.0133.2127.771.
- 2. (S)-N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl] acetamide, crystal “Form II” with an infrared (IR) spectrum as a mineral oil mull: 3364, 1748, 1675, 1537, 1517, 1445, 1410, 1401, 1358, 1329, 1287, 1274, 1253, 1237, 1221, 1145, 1130, 1123, 1116, 1078, 1066, 1049, 907, 852 and 758 cm−1.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a divisional of U.S. patent application Ser. No. 09/772,239, filed Jan. 29, 2001 now U.S. Pat. No. 6,444,813 and claims the benefit of the following provisional application: U.S. Ser. No. 60/179,837, filed Feb. 2, 2000, under 35 USC §119(e)(i).
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5688792 |
Barbachyn et al. |
Nov 1997 |
A |
5837870 |
Pearlman et al. |
Nov 1998 |
A |
Foreign Referenced Citations (2)
Number |
Date |
Country |
WO9737980 |
Oct 1997 |
WO |
WO9924393 |
May 1999 |
WO |
Non-Patent Literature Citations (4)
Entry |
J. Med. Chen., vol. 39, 1996, pp. 673-679, XP002168553. |
“Linezolid. Oxazolidinone Antibacterial” Drugs of the Future, es, barcelona, vol. 21, No. 11, 1996, pp. 1116-1123 XP000654643. |
Tetrahedron Letters, 40(26), 4855 (1999). |
Zurenko G E Et Al, Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolid candidates eperezolid and linezolid Expert opinion on Investigational Drugs, GB, Ashley Pub. Ltd. London, vol. 6, No. 2, 1997, pp. 151-158 XP000654528. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/179837 |
Feb 2000 |
US |